THC

Here, we bring you our top five recent articles covering veterans and medical cannabis, cannabis legalized by the Omaha tribe, low THC extracts for Rett syndrome, ICE raids at a cannabis farm, and our newest Noid Factoid.

According to a recent study, low THC cannabis extracts could be a potential tool for children diagnosed with Rett Syndrome.

Data from a recent study discovered that THC labeling was more accurate in concentrate products than with cannabis flower.

Despite federal hurdles, WSU researchers at the Center for Cannabis Policy Research and Outreach (CCPRO) are expanding cannabis science and collaboration.

Industry organizations respond after Governor Greg Abbott vetoed SB 3, citing safety and legal concerns.

The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.

A recent study found that CBD gummies may not have accurate labeling on how much the cannabinoid it contains.

Industry stakeholders responded to the bill, which would prohibit the sale and possession of hemp-derived THC, among other restrictions.

The effect of orally ingested cannabis on information processing speed, sustained and divided attention, inhibitory control, and mental flexibility was measured.

Topically applied cannabinoids such as CBD and THC may offer significant benefits for people experiencing localized pain and dermatological conditions. This article explores these potential benefits as well as their mechanisms.

Here, we bring you our top four recent articles covering research on cannabis and multiple sclerosis, New York’s Responsible Workforce Training program, veteran use of natural products, and testimony from the US Hemp Roundtable.

A recent study explored how vaporized cannabis consisting of a standardized THC and CBD formulation may help improve symptoms of MS patients.

The study measured children’s exposure to in-home cannabis smoke through biomarkers in urine samples.

Check out the complete series from our Cannabis Analysis column.

Here, Scott Mazza, Founder of Vitality CBD, discusses what science and law say about the cannabinoid THCA.

Accredited by A2LA, the scope of accreditation to ISO/IEC 17043 now includes six cannabis and hemp oil proficiency testing programs.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Here, we discuss the importance of calibration metrics and how to measure calibration quality.

This review highlights an in-silico assessment of the binding interactions of pro-drug moiety analogs and an importance in identifying potential issues that would need further testing to ensure safety for consumers such as the hERG values which are pertinent in the pharmaceutical fields in whether or not drugs can be safe to use.

Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.

This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.

This article discusses the early experiments and studies on the effects of two cannabinoids on anxiety.

As markets mature, manufacturing terpene blends have become a new art form and a differentiating factor for potential therapeutic applications. Here, we dive deeper into the insights of terpene formulation considerations.

In this blog installment, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.

This blog installment looks at the use of cannabis for pets. Topics covered include the history of cannabis use in veterinary medicine, current laws on cannabis for pets, market size and segment, reported experiences from both pet owners and veterinarians, and pet toxicology.

Brandy Young, PhD, the CEO and Founder of Certainty Analytical Labs in New York, discussed her work in compliance testing for cannabis products at EAS 2023.

Whether someone is struggling with acute or chronic pain, cannabis can be a powerful tool as an alternative or adjunct treatment.

One recently published study suggests that a cannabis sublingual spray may be beneficial in the treatment of type 2 diabetes.